Cargando…
Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom
The objective was to compare the incidence of adverse reactions reported with three nonsteroidal anti-inflammatory drugs with different cyclo-oxygenase (COX)-2 selectivity. All spontaneous adverse reaction notifications in the pharmacovigilance database of the World Health Organisation Collaborating...
Autores principales: | Raber, Anna, Heras, Joan, Costa, Joan, Fortea, Josep, Cobos, Albert |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1936304/ https://www.ncbi.nlm.nih.gov/pubmed/18360631 |
Ejemplares similares
-
Assessment of Dissolution Profile of Marketed Aceclofenac Formulations
por: Soni, T, et al.
Publicado: (2010) -
Synergistic effect of gefitinib and rofecoxib in mesothelioma cells
por: Stoppoloni, Daniela, et al.
Publicado: (2010) -
Selective inhibition of prostacyclin synthase activity by rofecoxib
por: Griffoni, Cristiana, et al.
Publicado: (2007) -
An evaluation of completeness of tuberculosis notification in the United Kingdom
por: Pillaye, Jayshree, et al.
Publicado: (2003) -
Development and Evaluation of Pharmacosomes of Aceclofenac
por: Semalty, A., et al.
Publicado: (2010)